tiprankstipranks
Brooklyn ImmunoTherapeutics (BTX)
NASDAQ:BTX
US Market

Brooklyn ImmunoTherapeutics (BTX) Cash flow

0 Followers

Brooklyn ImmunoTherapeutics Cash Flow

BTX's free cash flow for Q was $-4.18M. For the fiscal year, BTX's free cash flow was decreased by $-15.50M and operating cash flow was $-3.99M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20
Operating Cash Flow
$ -22.68M$ -23.49M$ -8.10M
Investing Cash Flow
$ -23.14M$ -22.74M$ -39.00K
Financing Cash Flow
$ 15.06M$ 61.59M$ 4.67M
Cash Flow From Discontinued Operation
---
Other Cash Adjustment Inside Changein Cash
---
End Cash Position
$ 84.27M$ 16.98M$ 1.63M
Income Tax Paid Supplemental Data
$ 1.00K$ 1.00K$ 0.00
Interest Paid Supplemental Data
$ 239.00K$ 225.00K$ 0.00
Issuance Of Capital Stock
$ 15.49M$ 62.52M$ 4.36M
Issuance Of Debt
-$ 0.00$ 310.00K
Repayment Of Debt
$ -410.01K$ -942.00K$ 0.00
Free Cash Flow
$ -23.07M$ -23.64M$ -8.14M
Domestic Sales
---
Foreign Sales
---
Currency in USD

Brooklyn ImmunoTherapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis